158 related articles for article (PubMed ID: 8852444)
41. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
42. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
44. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations.
Szulman AE; Surti U
Am J Obstet Gynecol; 1978 Jul; 131(6):665-71. PubMed ID: 686053
[TBL] [Abstract][Full Text] [Related]
45. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
[TBL] [Abstract][Full Text] [Related]
46. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
47. Expression of nm23-H1 in hydatidiform mole and its relationship with the development of postmolar disease.
Iwase K; Okamoto T; Nui R; Mizutani S
Gynecol Obstet Invest; 2001; 51(4):228-32. PubMed ID: 11408732
[TBL] [Abstract][Full Text] [Related]
48. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen.
Cheung AN; Ngan HY; Collins RJ; Wong YL
J Clin Pathol; 1994 Jul; 47(7):601-4. PubMed ID: 8089214
[TBL] [Abstract][Full Text] [Related]
49. A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression.
Lee Y; Kim KR; McKeon F; Yang A; Boyd TK; Crum CP; Parast MM
Hum Pathol; 2007 Jul; 38(7):1003-1013. PubMed ID: 17397906
[TBL] [Abstract][Full Text] [Related]
50. [Expression of TM4SF9 in human trophoblasts].
Gao TY; Yu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
[TBL] [Abstract][Full Text] [Related]
51. Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease.
Cameron B; Gown AM; Tamimi HK
Am J Obstet Gynecol; 1994 Jun; 170(6):1616-21; discussion 1621-2. PubMed ID: 7911272
[TBL] [Abstract][Full Text] [Related]
52. Telomerase activity in complete hydatidiform mole.
Sukcharoen N; Mutirangura A; Limpongsanurak S
J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
[TBL] [Abstract][Full Text] [Related]
53. Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease.
Murad TM; Longley JV; Lurain JR; Brewer JI
Int J Gynaecol Obstet; 1990 Aug; 32(4):359-67. PubMed ID: 1977631
[TBL] [Abstract][Full Text] [Related]
54. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.
Uzunlar AK; Yilmaz F; Bayhan G; Akkuş Z
Eur J Gynaecol Oncol; 2002; 23(1):79-83. PubMed ID: 11876401
[TBL] [Abstract][Full Text] [Related]
55. Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy.
Burton JL; Lidbury EA; Gillespie AM; Tidy JA; Smith O; Lawry J; Hancock BW; Wells M
Histopathology; 2001 May; 38(5):409-17. PubMed ID: 11422477
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of trophoblastic proliferation in complete hydatidiform moles in predicting persistent disease.
Horn LC; Kowalzik J; Bilek K; Richter CE; Einenkel J
Pathol Res Pract; 2006; 202(3):151-6. PubMed ID: 16436315
[TBL] [Abstract][Full Text] [Related]
57. [Persistent gestational trophoblastic disease following ectopic molar pregnancy].
Voloshchuk IN; Barinova IV; Buyanova SN; Petrakova SA; Shchukina NA; Mgeliashvili MV
Arkh Patol; 2021; 83(1):44-48. PubMed ID: 33512127
[TBL] [Abstract][Full Text] [Related]
58. [Immunohistochemical study on trophoblast subpopulations in normal pregnancy and trophoblastic disease].
Sasagawa M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2010-8. PubMed ID: 3001198
[TBL] [Abstract][Full Text] [Related]
59. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.
Ladines-Llave CA; Maruo T; Manalo AM; Mochizuki M
Cancer; 1993 Jun; 71(12):4118-23. PubMed ID: 7685239
[TBL] [Abstract][Full Text] [Related]
60. PHENOTYPIC CHARACTERISTICS OF CHORIONIC VILLI DURING GESTATIONAL TROPHOBLASTIC DISEASES.
Chikvaidze N; Kintraia N; Muzashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 Jan; (286):140-145. PubMed ID: 30829607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
